Marc De Meulemeester

944 total citations
9 papers, 557 citations indexed

About

Marc De Meulemeester is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, Marc De Meulemeester has authored 9 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Marc De Meulemeester's work include Gout, Hyperuricemia, Uric Acid (6 papers), Urticaria and Related Conditions (5 papers) and Case Reports on Hematomas (3 papers). Marc De Meulemeester is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (6 papers), Urticaria and Related Conditions (5 papers) and Case Reports on Hematomas (3 papers). Marc De Meulemeester collaborates with scholars based in United States, Switzerland and Belgium. Marc De Meulemeester's co-authors include Naomi Schlesinger, Peter Sallstig, Udayasankar Arulmani, Alexander So, Eftal Yücel, Dominik Richard, V. Murphy, A. Pikhlak, Eduardo Mysler and Hsiao‐Yi Lin and has published in prestigious journals such as The Journal of Infectious Diseases, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Marc De Meulemeester

8 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc De Meulemeester United States 6 377 264 236 222 103 9 557
Vedat Gerdan Türkiye 6 113 0.3× 345 1.3× 82 0.3× 112 0.5× 198 1.9× 11 446
C Duvic France 10 38 0.1× 92 0.3× 57 0.2× 63 0.3× 21 0.2× 24 298
K Nishiya Japan 10 59 0.2× 79 0.3× 49 0.2× 121 0.5× 129 1.3× 37 456
M Dervichian France 7 155 0.4× 457 1.7× 94 0.4× 30 0.1× 275 2.7× 13 503
Kaori Muro Japan 8 186 0.5× 70 0.3× 26 0.1× 35 0.2× 68 0.7× 12 304
Ramazan Uçar Türkiye 10 31 0.1× 48 0.2× 85 0.4× 22 0.1× 73 0.7× 29 322
Marie Carlson Sweden 9 80 0.2× 60 0.2× 94 0.4× 11 0.0× 95 0.9× 15 393
Margaret J. Maclachlan Canada 6 78 0.2× 63 0.2× 48 0.2× 73 0.3× 41 0.4× 9 320
Mohit Mathur United States 11 194 0.5× 31 0.1× 24 0.1× 70 0.3× 63 0.6× 42 377
Dongyuan Xia United States 9 17 0.0× 79 0.3× 112 0.5× 27 0.1× 206 2.0× 13 411

Countries citing papers authored by Marc De Meulemeester

Since Specialization
Citations

This map shows the geographic impact of Marc De Meulemeester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc De Meulemeester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc De Meulemeester more than expected).

Fields of papers citing papers by Marc De Meulemeester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc De Meulemeester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc De Meulemeester. The network helps show where Marc De Meulemeester may publish in the future.

Co-authorship network of co-authors of Marc De Meulemeester

This figure shows the co-authorship network connecting the top 25 collaborators of Marc De Meulemeester. A scholar is included among the top collaborators of Marc De Meulemeester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc De Meulemeester. Marc De Meulemeester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Borne, Philippe van de, André Peeters, Luc Janssens, et al.. (2022). Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study. Acta cardiologica. Supplementum. 79(1). 20–29. 7 indexed citations
2.
Meulemeester, Marc De, Elsa F Mateus, Neil Betteridge, et al.. (2020). Understanding the patient voice in gout: a quantitative study conducted in Europe. BJGP Open. 4(1). bjgpopen20X101003–bjgpopen20X101003. 7 indexed citations
3.
Meulemeester, Marc De, Tim Jansen, G. Petersen, & Fernando Pérez-Ruiz. (2019). OP0157 HPR EUROPEAN PATIENT VOICE IN GOUT SURVEY – SUBJECTIVE SATISFACTION IN GOUT PATIENTS VERSUS OBJECTIVE SUBOPTIMAL GOUT CARE. Annals of the Rheumatic Diseases. 78. 153–154.
4.
Meulemeester, Marc De, Didier Giet, Giancarlo Icardi, et al.. (2011). Immunogenicity profile of a 3.75-Ug hemagglutinin pandemic rH5N1 split virion As03A-adjuvanted vaccine in elderly persons : a randomized trial. Open Repository and Bibliography (University of Liège). 3 indexed citations
5.
Meulemeester, Marc De, Didier Giet, Giancarlo Icardi, et al.. (2011). Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03A-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial. The Journal of Infectious Diseases. 203(8). 1054–1062. 27 indexed citations
6.
Meulemeester, Marc De, A. Pikhlak, Eftal Yücel, et al.. (2011). Metabolic and crystal arthropathies: 112. Rapid Improvement in Health-Related Quality of Life in Gouty Arthritis Patients Treated with Canakinumab (ACZ885) Compared to Triamcinolone Acetonide. Lara D. Veeken. 50(Supplement 3). iii85–iii86. 3 indexed citations
7.
8.
Schlesinger, Naomi, Eduardo Mysler, Hsiao‐Yi Lin, et al.. (2011). Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Annals of the Rheumatic Diseases. 70(7). 1264–1271. 175 indexed citations
9.
So, Alexander, Marc De Meulemeester, A. Pikhlak, et al.. (2010). Canakinumab for the treatment of acute flares in difficult‐to‐treat gouty arthritis: Results of a multicenter, phase II, dose‐ranging study. Arthritis & Rheumatism. 62(10). 3064–3076. 226 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vedat Gerdan Breakdown of academic impact, for papers by C Duvic Breakdown of academic impact, for papers by K Nishiya Breakdown of academic impact, for papers by M Dervichian Breakdown of academic impact, for papers by Kaori Muro Breakdown of academic impact, for papers by Ramazan Uçar Breakdown of academic impact, for papers by Marie Carlson Breakdown of academic impact, for papers by Margaret J. Maclachlan Breakdown of academic impact, for papers by Mohit Mathur Breakdown of academic impact, for papers by Dongyuan Xia
Rankless by CCL
2026